IGM Biosciences Inc (IGMS)
8.89
-0.88
(-8.96%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.14
(-1.57%)
After-Hours: 20:00
IGM Biosciences Total Liabilities (Quarterly): 225.56M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 225.56M |
| June 30, 2024 | 214.14M |
| March 31, 2024 | 214.88M |
| December 31, 2023 | 220.18M |
| September 30, 2023 | 220.49M |
| June 30, 2023 | 222.05M |
| March 31, 2023 | 223.31M |
| December 31, 2022 | 226.24M |
| September 30, 2022 | 212.76M |
| June 30, 2022 | 206.79M |
| March 31, 2022 | 53.22M |
| December 31, 2021 | 53.22M |
| Date | Value |
|---|---|
| September 30, 2021 | 46.65M |
| June 30, 2021 | 28.21M |
| March 31, 2021 | 24.86M |
| December 31, 2020 | 26.82M |
| September 30, 2020 | 23.54M |
| June 30, 2020 | 22.10M |
| March 31, 2020 | 19.14M |
| December 31, 2019 | 21.12M |
| September 30, 2019 | 15.23M |
| June 30, 2019 | 6.701M |
| December 31, 2018 | 69.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.14M
Minimum
Mar 2020
226.24M
Maximum
Dec 2022
125.26M
Average
130.00M
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna Inc | 3.876B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 304.51M |
| Shareholders Equity (Quarterly) | 78.95M |
| Current Ratio | 5.223 |